In 2025, compounding surged in the US as a workaround during GLP-1 shortages, with telehealth providers stepping in to meet demand
Fortunately, weight loss injections help with the following health conditions: Type 2 diabetes Heart disease High blood pressure High cholesterol Joint pain due to being overweight 3
BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
They're not at this time considered right for everyone